Sherwin-Williams stock price target cut by Goldman on lower peer multiples

Goldman Sachs cut Sherwin-Williams' (SHW) price target to $410 from $420, citing lower peer multiples. It also adjusted targets for Axta (AXTA), PPG (PPG), Tronox (TROX), Kronos (KRO), and Chemours (CC). Goldman noted mixed industry trends, including stable architectural coatings demand and raw material headwinds. Price targets were lowered for SHW, PPG, TROX, KRO, and CC, while AXTA's target was raised.

Original reporting
Published Oct 9, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SHW
Bearish
high confidence
Mentioned
$SHW · $AXTA · $PPG · $TROX · $KRO · $CC
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SHWBearishMed
01

Why it matters

The revisions signal a reassessment of earnings outlooks and valuation levels, prompting traders to re‑evaluate positions in the affected stocks.

02

Market read

Analyst target changes are a common catalyst that can move stock prices, especially for mid‑cap industrial names.

03

What to watch

Potential upside from upcoming raw‑material cost stabilization or new contract wins not yet reflected in the targets.

Relevance 6/10Novelty 7/10Timing: premarket today

Background

Goldman Sachs released a sector‑wide price‑target update for several US‑listed coatings and chemicals companies, adjusting multiples based on peer valuation and market conditions.

Company-level read

Ticker impact

$SHWBearishHigh confidence
Context

Goldman Sachs lowered its price target on Sherwin‑Williams to $410, citing slightly lower peer multiples.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target reduction reflects weaker relative valuation, which may prompt sellers.

$AXTABullishHigh confidence
Context

Goldman raised its price target on Axta Coating Systems to $38, applying a higher multiple.

Expected impact

potential upside as investors price in the higher target

Evidence & confidence

Higher multiple signals improved earnings outlook, supporting a rally.

$PPGBearishHigh confidence
Context

Goldman lowered its price target on PPG Industries to $128, reducing the valuation multiple.

Expected impact

likely pressure as the market adjusts to the lower target

Evidence & confidence

Reduced multiple suggests weaker growth expectations.

$TROXBearishHigh confidence
Context

Goldman lowered its price target on Tronox to $4 from $6.5, citing elevated headwinds.

Expected impact

likely pressure as investors react to the steep cut

Evidence & confidence

The large downgrade reflects deteriorating fundamentals.

$KROBearishMedium confidence
Context

Goldman maintained its Sell rating and $8 price target on Kronos Worldwide.

Expected impact

potential pressure as the market aligns with the Sell stance

Evidence & confidence

No upgrade; the Sell rating reinforces bearish sentiment.

$CCBearishMedium confidence
Context

Goldman gave Chemours a Neutral rating with a $16 price target, down from $17.

Expected impact

likely modest pressure as the market absorbs the lower target

Evidence & confidence

Neutral rating and lower target indicate limited upside.

Market effects

Analyst target revisions may shift sentiment across the coatings and chemicals sector.

US investors may adjust exposure to related peers based on the revised multiples.

Limited to North American markets; no immediate global macro impact.

Counterpoint

Some investors may view the cuts as over‑reactive and look for buying opportunities on the dip.

Key entities

  • Goldman Sachs

    Equity research firm issuing the price‑target changes.

Related articles

$TROXMedAI 8/10

Tronox Reports Third Quarter 2026 Financial Results

Tronox Holdings plc (TROX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tronox Reports Third Quarter 2026 Financial Results Third quarter financial results in-line with prior guidance STAMFORD, Conn., November 4, 2026/PRNewswire/ — Tronox Holdings plc (NYSE:TROX) (“Tronox” or the “Company”), the world’s leading integrated manufacturer of

$CCMed

The Chemours Co (CC) (Q3 2026) Earnings Call Highlights: Pricing Momentum and AI-Driven

The Chemours Co (CC) reported Q3 2026 earnings, highlighting pricing momentum and AI-driven demand. The company lowered its free cash flow conversion outlook to 15%-20%, citing legal settlements and working capital timing. Q4 net sales for TSS are expected to decline 15%-20% due to seasonality, with adjusted EBITDA of $105-$115 million. TT's adjusted EBITDA is guided to $60-$65 million.

$CCMed

Canton CC Rises 4% After SEC Staff No-Action Letter

Canton Coin (CC) rose 4% after the SEC staff issued a no-action letter viewing it as a 'digital commodity.' The letter is not binding but indicates the SEC may not pursue enforcement action over CC's issuance under described conditions. CC traded at $0.098, down 4.2% over the past week, according to CoinMarketCap.

$CCMedAI 8/10

Chemours (CC) Q3 2026 Earnings Call Transcript

Chemours (CC) reported Q3 2026 adjusted EBITDA of $200M, above guidance. TSS saw lower demand for Opteon blends, while TT and APM exceeded expectations. The company settled litigation with North Carolina and received final approval for a New Jersey consent order. Guidance for Q4 includes seasonal declines in sales and EBITDA for TSS and TT, with APM showing growth in Performance Solutions.

$CCHigh

What Chemours (CC) Said on Its Q3 Earnings Call

Chemours (CC) expects Q4 net sales to decline in high-single-digit to low-teens range and adjusted EBITDA of $60M-$65M, citing seasonality and weaker demand. APM sales rose 26% YoY, driven by AI infrastructure demand, with Q4 sales expected to increase in low- to mid-teens range. TSS faces seasonal aftermarket softness, with Q4 sales expected to decline in high-teens to low-20% range. Full-year net sales are expected to increase about 2% compared with 2025, with adjusted EBITDA of $775M-$800M.